A major discovery in cancer investigation is arising with the use of mini-antibodies to re-engage mutated p53. This essential malignant inhibitor protein is frequently lost in various forms of tumors, causing https://bookmarkbells.com/story22024979/nanobodies-reactivate-the-p53-protein-a-promising-pathway-for-tumor-management